Health Condition 1: R69- Illness, unspecified Health Condition 2: Z768- Persons encountering health services in other specified circumstances
Conditions
Interventions
Intervention1: use of virtual reality device: (i) VR Group (VRG): A head-mounted display showing calming natural scenes with immersive audio will be securely fitted 5 minutes before propofol administr
Sponsors
DEPARTMENT OF ANAESTHESIOLOGY
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients (18-65 years) of either gender, American Society of Anaesthesiologists (ASA) Class I-II scheduled for elective surgery under general anaesthesia
Exclusion criteria
Exclusion criteria: Unable or unwilling to provide informed consent, such as patients with delirium, severe cognitive impairment, or a language barrier without an available translator. Pregnancy. Emergency surgery. Requirement for rapid sequence intubation. Anticipated difficult bag mask ventilation. Allergy to any of the study drugs or contraindications to the use of propofol or lignocaine. Chronic pain or diabetic neuropathy. Glasgow Coma Scale score less than 15. Anticipated difficult venous access on the dorsum of the hand. Visual impairment or hearing impairment. Seizure disorder. Psychiatric illness. Patients already receiving opioid therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of virtual reality (VR) in preventing pain during propofol injection.Timepoint: 20seconds post propofol injection | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess adverse effects, if any, related to the use of VR. 2. to compare induction dose of propofol as well as hemodynamic changes (heart rate, blood pressure) at induction, between the groups. Timepoint: every 2 minutes for 3 point during induction | — |
Countries
India
Contacts
Public ContactDr Sandeep Khuba
Sanjay Gandhi post graduate institute of medical sciences
Outcome results
None listed